Lipitor (atorvastatin) was introduced in 1996 by Warner-Lambert Company, which was subsequently acquired by Pfizer. Individuals diagnosed with diabetes after Lipitor use may be entitled to financial compensation through a product liability lawsuit. Amid agressive marketing and promotion, the cholesterol drug became one of the top selling brand name drugs in the world, generating more than $125 billion in sales before generic Lipitor became available in 2011.
Lipitor is a member of a class of drugs known as “statins”, which work by preventing the liver from creating an enzyme that helps the body produce cholesterol. This helps the body reduce the levels of low-density lipoprotein (LDL) cholesterol, often referred to as “bad cholesterol.” Statins have been linked to a number of serious health problems and side effects, including muscle injury, kidney problems, and diabetes.
Complaints have been filed in courts throughout the country on behalf of individuals diagnosed with diabetes from Lipitor, and additional claims are being reviewed as a result of Pfizer’s decision to place their desire for profits before consumer safety.
Some Common allegations raised in Lipitor diabetes lawsuits
Lipitor can have dangerous side effects
- Pfizer knew or should have known that Lipitor causes type 2 diabetes and may increase blood glucose levels, yet continued to market the medication as safe and effective.
- Lipitor is defective and unsafe because it is not accompanied by proper warnings about the potential side effects of developing diabetes.
- Drug makers have a duty to properly research medications and provide proper warnings to inform users and the medical community about unreasonable and dangerous risks.
Chat about your case 24hrs a day
- Pfizer failed to perform appropriate studies of Lipitor before it was introduced or conduct adequate surveillance of Lipitor problems reported by users after it was sold
- Pfizer was overly aggressive and deceitful in marketing and promoting the use of Lipitor, resulting in billions of dollars in annual sales revenue.
- If proper warnings were provided, individuals may have avoided the risk of diabetes by deciding not to use Lipitor or by closely monitoring blood glucose levels to see if the drug was adversely affecting their metabolism.